• 1
    Parola P, Raoult D. Tick-borne bacterial diseases emerging in Europe. Clin Microbiol Infect 2001; 7: 8083.
  • 2
    Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis 2001; 32: 897928.
  • 3
    Roux V, Raoult D. Phylogenetic analysis of the genus Rickettsia by 16S rDNA sequencing. Res Microbiol 1995; 146: 385396.
  • 4
    Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 1997; 10: 694719.
  • 5
    Raoult D, Brouqui P, Roux V. A new spotted-fever-group rickettsiosis. Lancet 1996; 348: 412.
  • 6
    Fournier PE, Tissot-Dupont H, Gallais H et al. Rickettsia mongolotimonae: a rare pathogen in France. Emerg Infect Dis 2000; 6: 290292.
  • 7
    Lakos A. Tick-borne lymphadenopathy (TIBOLA). Wien Klin Wochenschr 2002; 114: 648654.
  • 8
    Raoult D, Lakos A, Fenollar F et al. Spotless rickettsiosis caused by Rickettsia slovaca and associated with Dermacentor ticks. Clin Infect Dis 2002; 34: 13311336.
  • 9
    Fournier PE, Gunnenberger F, Jaulhac B et al. Evidence of Rickettsia helvetica infection in humans, Eastern France. Emerg Infect Dis 2000; 6: 389392.
  • 10
    Bacellar F, Beati L, Franca A et al. Israeli spotted fever rickettsia (Rickettsia conorii complex) associated with human disease in Portugal. Emerg Infect Dis 1999; 5: 835836.
  • 11
    Tarasevich IV, Makarova VA, Fetisova NF et al. Astrakhan fever, a spotted-fever rickettsiosis. Lancet 1991; 337: 172173.
  • 12
    Raoult D, Fournier PE, Fenollar F et al. Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa. N Engl J Med 2001; 344: 15041510.
  • 13
    Jensenius M, Fournier PE, Vene S et al. African tick bite fever in travelers to rural sub-Equatorial Africa. Clin Infect Dis 2003; 36: 14111417.
  • 14
    Paddock CD, Sumner JW, Comer JA et al. Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis 2004; 38: 805811.
  • 15
    Drancourt M, Raoult D, Harlé JR et al. Biological variations in 412 patients with Mediterranean spotted fever. Ann NY Acad Sci 1990; 590: 3950.
  • 16
    Jensenius M, Fournier PE, Hellum KB et al. Sequential changes in hematologic and biochemical parameters in African tick bite fever. Clin Microbiol Infect 2003; 9: 678683.
  • 17
    Nilsson K, Lindquist O, Pahlson C. Association of Rickettsia helvetica with chronic perimyocarditis in sudden cardiac death. Lancet 1999; 354: 11691173.
  • 18
    La Scola B, Raoult D. Diagnosis of Mediterranean spotted fever by cultivation of Rickettsia conorii from blood and skin samples using the centrifugation–shell vial technique and by detection of R. conorii in circulating endothelial cells: a 6-year follow-up. J Clin Microbiol 1996; 34: 27222727.
  • 19
    Fenollar F, Raoult D. Diagnosis of rickettsial diseases using samples dried on blotting paper. Clin Diagn Lab Immunol 1999; 6: 483488.
  • 20
    La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 1997; 35: 27152727.
  • 21
    Fournier PE, Jensenius M, Laferl H et al. Kinetics of antibody responses in Rickettsia africae and Rickettsia conorii infections. Clin Diagn Lab Immunol 2002; 9: 324328.
  • 22
    Rolain JM, Shpynov S, Raoult D. Spotted-fever-group rickettsioses in north Asia. Lancet 2003; 362: 1939 .
  • 23
    La Scola B, Rydkina L, Ndihokubwayo JB et al. Serological differentiation of murine typhus and epidemic typhus using cross-adsorption and Western blotting. Clin Diagn Lab Immunol 2000; 7: 612616.
  • 24
    Teysseire N, Raoult D. Comparison of Western immunoblotting and microimmunofluorescence for diagnosis of Mediterranean spotted fever. J Clin Microbiol 1992; 30: 455460.
  • 25
    Gimenez DF. Staining rickettsiae in yolk-sac cultures. Stain Technol 1964; 39: 135140.
  • 26
    Marrero M, Raoult D. Centrifugation–shell vial technique for rapid detection of Mediterranean spotted fever rickettsia in blood culture. Am J Trop Med Hyg 1989; 40: 197199.
  • 27
    Chen SM, Dumler JS, Bakken JS et al. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994; 32: 589595.
  • 28
    Dumler JS, Barbet AF, Bekker CP et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and ‘HGE agent’ as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001; 51: 21452165.
  • 29
    Macleod J. Preliminary studies in the tick transmission of loupin ill. II. A study of the recation of sheep to tick infestation. Vet J 1932; 88: 276284.
  • 30
    Parola P, Beati L, Cambon M et al. Ehrlichial DNA amplified from Ixodes ricinus (Acari: Ixodidae) in France. J Med Entomol 1998; 35: 180183.
  • 31
    Petrovec M, Sumner JW, Nicholson WL et al. Identity of ehrlichial DNA sequences derived from Ixodes ricinus ticks with those obtained from patients with human granulocytic ehrlichiosis in Slovenia. J Clin Microbiol 1999; 37: 209210.
  • 32
    Pusterla N, Leutenegger CM, Huder JB et al. Evidence of the human granulocytic ehrlichiosis agent in Ixodes ricinus ticks in Switzerland. J Clin Microbiol 1999; 37: 13321334.
  • 33
    Liz JS, Anderes L, Sumner JW et al. PCR detection of granulocytic ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerland. J Clin Microbiol 2000; 38: 10021007.
  • 34
    Schouls LM, Van De Pol I, Rijpkema SG et al. Detection and identification of Ehrlichia, Borrelia burgdorferi sensu lato, and Bartonella species in Dutch Ixodes ricinus ticks. J Clin Microbiol 1999; 37: 22152222.
  • 35
    Cinco M, Padovan D, Murgia R et al. Coexistence of Ehrlichia phagocytophila and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks from Italy as determined by 16S rRNA gene sequencing. J Clin Microbiol 1997; 35: 33653366.
  • 36
    Christova IS, Dumler JS. Human granulocytic ehrlichiosis in Bulgaria. Am J Trop Med Hyg 1999; 60: 5861.
  • 37
    Jenkins A, Kristiansen BE, Allum AG et al. Borrelia burgdorferi sensu lato and Ehrlichia spp. in Ixodes ticks from southern Norway. J Clin Microbiol 2001; 39: 36663671.
  • 38
    Alekseev AN, Dubinina HV, Semenov AV et al. Evidence of ehrlichiosis agents found in ticks (Acari: Ixodidae) collected from migratory birds. J Med Entomol 2001; 38: 471474.
  • 39
    Baumgarten BU, Rollinghoff M, Bogdan C. Prevalence of Borrelia burgdorferi and granulocytic and monocytic ehrlichiae in Ixodes ricinus ticks from southern Germany. J Clin Microbiol 1999; 37: 34483451.
  • 40
    Fingerle V, Munderloh UG, Liegl G et al. Coexistence of ehrlichiae of the phagocytophila group with Borrelia burgdorferi in Ixodes ricinus from Southern Germany. Med Microbiol Immunol (Berl) 1999; 188: 145149.
  • 41
    Alberdi MP, Walker AR, Paxton EA et al. Natural prevalence of infection with Ehrlichia (Cytoecetes) phagocytophila of Ixodes ricinus ticks in Scotland. Vet Parasitol 1998; 78: 203213.
  • 42
    Oteo JA, Gil H, Barral M et al. Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain. Epidemiol Infect 2001; 127: 353358.
  • 43
    Petrovec M, Lotric FS, Zupanc TA et al. Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol 1997; 35: 15561559.
  • 44
    Brouqui P. Ehrlichiosis in Europe. In: RaoultD, BrouquiP, eds. Rickettsiae and rickettsial diseases at the turn of the third millenium. Paris: Elsevier, 1999; 220232.
  • 45
    Brouqui P, Dumler JS, Lienhard R et al. Human granulocytic ehrlichiosis in Europe. Lancet 1995; 346: 782783.
  • 46
    Skarphedinsson S, Sogaard P, Pedersen C. Seroprevalence of human granulocytic ehrlichiosis in high-risk groups in Denmark. Scand J Infect Dis 2001; 33: 206210.
  • 47
    Pusterla N, Weber R, Wolfensberger C et al. Serological evidence of human granulocytic ehrlichiosis in Switzerland. Eur J Clin Microbiol Infect Dis 1998; 17: 207209.
  • 48
    Hunfeld KP, Brade V. Prevalence of antibodies against the human granulocytic ehrlichiosis agent in Lyme borreliosis patients from Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 221224.
  • 49
    Bakken JS, Krueth J, Tilden RL et al. Serological evidence of human granulocytic ehrlichiosis in Norway. Eur J Clin Microbiol Infect Dis 1996; 15: 829832.
  • 50
    Fingerle V, Goodman JL, Johnson RC et al. Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups. J Clin Microbiol 1997; 35: 32443247.
  • 51
    Hulinska D, Votypka J, Plch J et al. Molecular and microscopical evidence of Ehrlichia spp. and Borrelia burgdorferi sensu lato in patients, animals and ticks in the Czech Republic. New Microbiol 2002; 25: 437448.
  • 52
    Daniel SA, Manika K, Arvanitidou M et al. Serologic evidence of human granulocytic ehrlichiosis, Greece. Emerg Infect Dis 2002; 8: 643644.
  • 53
    Walder G, Tiwald G, Dierich MP et al. Serological evidence for human granulocytic ehrlichiosis in Western Austria. Eur J Clin Microbiol Infect Dis 2003; 22: 543547 .
  • 54
    Van Dobbenburgh A, Van Dam AP, Fikrig E. Human granulocytic ehrlichiosis in western Europe. N Engl J Med 1999; 340: 12141216.
  • 55
    Karlsson U, Bjoersdorff A, Massung RF et al. Human granulocytic ehrlichiosis—a clinical case in Scandinavia. Scand J Infect Dis 2001; 33: 7374.
  • 56
    Bjoersdorff A, Wittesjo B, Berglun J et al. Human granulocytic ehrlichiosis as a common cause of tick-associated fever in Southeast Sweden: report from a prospective clinical study. Scand J Infect Dis 2002; 34: 187191.
  • 57
    Lotric-Furlan S, Petrovec M, Zupanc TA et al. Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin Infect Dis 1998; 27: 424428.
  • 58
    Laferl H, Hogrefe W, Kock T et al. A further case of acute human granulocytic ehrlichiosis in Slovenia. Eur J Clin Microbiol Infect Dis 1999; 18: 385386.
  • 59
    Arnez M, Petrovec M, Lotric-Furlan S et al. First European pediatric case of human granulocytic ehrlichiosis. J Clin Microbiol 2001; 39: 45914592.
  • 60
    Lotric-Furlan S, Petrovec M, Avsic-Zupanc T et al. Human granulocytic ehrlichiosis in Slovenia. Ann NY Acad Sci 2003; 990: 279284.
  • 61
    Oteo JA, Blanco JR, Martinez DA et al. First report of human granulocytic ehrlichiosis from southern Europe (Spain). Emerg Infect Dis 2000; 6: 430432.
  • 62
    Walder G, Falkensammer B, Aigner J et al. First documented case of human granulocytic ehrlichiosis in Austria. Wien Klin Wochenschr 2003; 115: 263266.
  • 63
    Tylewska-Wierzbanowska S, Chmielewski T, Kondrusik M et al. First cases of acute human granulocytic ehrlichiosis in Poland. Eur J Clin Microbiol Infect Dis 2001; 20: 196198.
  • 64
    Remy V, Hansmann Y, De Martino SJ et al. Human anaplasmosis presenting as atypical pneumonitis in France. Clin Infect Dis 2003; 37: 846848 .
  • 65
    Lotric-Furlan S, Avsic-Zupanc T, Petrovec M et al. Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. Clin Diagn Lab Immunol 2001; 8: 899903.
  • 66
    Lotric-Furlan S, Petrovec M, Avsic-Zupanc T et al. Clinical distinction between human granulocytic ehrlichiosis and the initial phase of tick-borne encephalitis. J Infect 2000; 40: 5558.
  • 67
    Lotric-Furlan S, Petrovec M, Avsic-Zupanc T et al. Epidemiological, clinical and laboratory distinction between human granulocytic ehrlichiosis and the initial phase of tick-borne encephalitis. Wien Klin Wochenschr 2002; 114: 636640.
  • 68
    Foggie A. Studies on the infectious agent of tick borne fever in sheep. J Pathol Bacteriol 1951; 63: 115.
  • 69
    Goodman JL, Nelson C, Vitale B et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996; 334: 209215.
  • 70
    Bjoersdorff A, Bagert B, Massung RF et al. Isolation and characterization of two European strains of Ehrlichia phagocytophila of equine origin. Clin Diagn Lab Immunol 2002; 9: 341343.
  • 71
    Brouqui P, Salvo E, Dumler JS et al. Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay. Clin Diagn Lab Immunol 2001; 8: 199202.
  • 72
    Edelman DC, Dumler JS. Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis. Mol Diagn 1996; 1: 4149.
  • 73
    Walls JJ, Caturegli P, Bakken JS et al. Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group ehrlichiae. J Clin Microbiol 2000; 38: 354356.
  • 74
    Massung RF, Slater KG. Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum. J Clin Microbiol 2003; 41: 717722.
  • 75
    Parola P, Roux V, Camicas JL et al. Detection of ehrlichiae in African ticks by polymerase chain reaction. Trans R Soc Trop Med Hyg 2000; 94: 707708.
  • 76
    Burgdorfer W, Barbour AG, Hayes SF et al. Lyme disease—a tick-borne spirochetosis? Science 1982; 216: 13171319.
  • 77
    Baranton G, Postic D, Saint Girons I et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992; 42: 378383.
  • 78
    Canica MM, Nato F, Du Merle L et al. Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis 1993; 25: 441448.
  • 79
    Barbour AG, Maupin GO, Teltow GJ et al. Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness. J Infect Dis 1996; 173: 403409.
  • 80
    James AM, Liveris D, Wormser GP et al. Borrelia lonestari infection after a bite by an Amblyomma americanum tick. J Infect Dis 2001; 183: 18101814.
  • 81
    Kawabata H, Masuzawa T, Yanagihara Y. Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovatus in Japan. Microbiol Immunol 1993; 37: 843848.
  • 82
    Marconi RT, Liveris D, Schwartz I. Identification of novel insertion elements, restriction fragment length polymorphism patterns, and discontinuous 23S rRNA in Lyme disease spirochetes: phylogenetic analyses of rRNA genes and their intergenic spacers in Borrelia japonica sp. nov. and genomic group 21038 (Borrelia andersonii sp. nov.) isolates. J Clin Microbiol 1995; 33: 24272434.
  • 83
    Le Fleche A, Postic D, Girardet K et al. Characterization of Borrelia lusitaniae sp. nov. by 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol 1997; 47: 921925.
  • 84
    Fukunaga M, Takahashi Y, Tsuruta Y et al. Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan. Int J Syst Bacteriol 1995; 45: 804810.
  • 85
    Fukunaga M, Hamase A, Okada K et al. Borrelia tanukii sp. nov. and Borrelia turdae sp. nov. found from ixodid ticks in Japan: rapid species identification by 16S rRNA gene-targeted PCR analysis. Microbiol Immunol 1996; 40: 877881.
  • 86
    Wang G, Van Dam AP, Le Fleche A et al. Genetic and phenotypic analysis of Borrelia valaisiana sp. nov. (Borrelia genomic groups VS116 and M19). Int J Syst Bacteriol 1997; 47: 926932.
  • 87
    Olsen B, Duffy DC, Jaenson TG et al. Transhemispheric exchange of Lyme disease spirochetes by seabirds. J Clin Microbiol 1995; 33: 32703274.
  • 88
    Humair PF, Gern L. The wild hidden face of Lyme borreliosis in Europe. Microb Infect 2000; 2: 915922.
  • 89
    Assous MV, Postic D, Paul G et al. Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens. Eur J Clin Microbiol Infect Dis 1993; 12: 261268.
  • 90
    Vandam AP, Kuiper H, Vos K et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993; 17: 708717.
  • 91
    Balmelli T, Piffaretti JC. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res Microbiol 1995; 146: 329340.
  • 92
    Wilske B, Schriefer ME. Borrelia . In: MurrayPR, BaronEJ, JorgensenJH, PfallerMA, YolkenRH, eds. Manual of clinical microbiology. Washington, DC: ASM Press, 2003; 937954.
  • 93
    Eiffert H, Ohlenbusch A, Christen HJ et al. Nondifferentiation between Lyme-disease spirochetes from vector ticks and human cerebrospinal fluid. J Infect Dis 1995; 171: 476479.
  • 94
    Nocton JJ, Dressler F, Rutledge BJ et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994; 330: 229234.
  • 95
    Jaulhac B, Heller R, Limbach FX et al. Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with lyme arthritis. J Clin Microbiol 2000; 38: 18951900.
  • 96
    Berger BW, Johnson RC, Kodner C et al. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol 1992; 30: 359361.
  • 97
    Asbrink E, Hovmark A. Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann NY Acad Sci 1988; 539: 415.
  • 98
    Hansen K, Lebech AM. Lyme neuroborreliosis—a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, immunoglobulin A, and immunoglobulin M. Ann Neurol 1991; 30: 197205.
  • 99
    Wilske B, Schierz G, PreacMursic V et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis 1986; 153: 304314.
  • 100
    Herzer P, Wilske B, PreacMursic V et al. Lyme arthritis—clinical features, serological, and radiographic findings of cases in Germany. Klin Wochenschr 1986; 64: 206215.
  • 101
    Wilske B, Schierz G, PreacMursic V et al. Serological diagnosis of erythema migrans disease and related disorders. Infection 1984; 12: 331337.
  • 102
    Wilske B, Fingerle V, Herzer P et al. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis—comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay. Med Microbiol Immunol 1993; 182: 255270.
  • 103
    Wilske B, Habermann C, Fingerle V et al. An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis. Med Microbiol Immunol 1999; 188: 139144.
  • 104
    Roessler D, Hauser U, Wilske B. Heterogeneity of BmpA (P39) among European isolates of Borrelia burgdorferi sensu lato and influence of interspecies variability on serodiagnosis. J Clin Microbiol 1997; 35: 27522758.
  • 105
    Wilske B, Fingerle V, PreacMursic V et al. Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato. Med Microbiol Immunol 1994; 183: 4359.
  • 106
    Schulte-Spechtel U, Lehnert G, Liegl G et al. Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. J Clin Microbiol 2003; 41: 12991303.
  • 107
    Association of State and Territorial Public Health Laboratory Directors and the Centers for Disease Control and Prevention. Proceedings of the second national conference on serological diagnosis of Lyme disease. Fort Collins, CO: Centers for Disease Control, 1995; 17.
  • 108
    Barbour AG. Immunochemical analysis of Lyme disease spirochetes. Yale J Biol Med 1984; 57: 581586.
  • 109
    Preac-Mursic V, Wilske B, Reinhardt S. Culture of Borrelia burgdorferi on six solid media. Eur J Clin Microbiol Infect Dis 1991; 10: 10761079.
  • 110
    Postic D, Merien F, Perolat P, Baranton G. Biological diagnosis: leptospirosis—Lyme borreliosis. Paris: Institut Pasteur, Collection des laboratoires de référence et d'expertise, 2000.
  • 111
    Wilske B. Microbiological diagnosis in Lyme borreliosis. Int J Med Microbiol 2002; 291: 114119.
  • 112
    Brettschneider S, Bruckbauer H, Klugbauer N et al. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 1998; 36: 26582665.
  • 113
    Stanek G, O'Connell S, Cimmino M et al. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996; 108: 741747.
  • 114
    Wong JD, Shapiro DS. Francisella . In: MurrayPR, BaronEJ, PfallerMA, TenoverFC, YolkenRH, eds. Manual of clinical microbiology. Washington, DC: ASM Press, 1999; 647651.
  • 115
    Varma RN. A note on a reliable distinguishing feature between the two closely allied scrub-typhus vectors, Leptotrombidium (L.) deliense and L (L) Akamushi. Ind J Med Sci 1972; 26: 430431.
  • 116
    Gurycova D. First isolation of Francisella tularensis subsp. tularensis in Europe. Eur J Epidemiol 1998; 14: 797802.
  • 117
    Cross JT, Penn RL. Francisella tularensis (tularemia). In: MandellGL, BennettJE, DolinR, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 2000; 23932402.
  • 118
    Morner T. The ecology of tularaemia. Rev Sci Tech 1992; 11: 11231130.
  • 119
    Hypsa V, Aksoy S. Phylogenetic characterization of two transovarially transmitted endosymbionts of the bedbug Cimex lectularius (Heteroptera: Cimicidae). Insect Mol Biol 1997; 6: 301304.
  • 120
    Syrjala H, Kujala P, Myllyla V et al. Airborne transmission of tularemia in farmers. Scand J Infect Dis 1985; 17: 371375.
  • 121
    Andres PC, Mateos-Baruque ML, Buron L et al. Epidemic outbreak of tularemia in Palencia. Rev Clin Esp 1999; 199: 711715.
  • 122
    Anda P, Segura DP, Diaz Garcia JM et al. Waterborne outbreak of tularemia associated with crayfish fishing. Emerg Infect Dis 2001; 7: 575582.
  • 123
    Greco D, Allegrini G, Tizzi T et al. A waterborne tularemia outbreak. Eur J Epidemiol 1987; 3: 3538.
  • 124
    Tarnvik A, Sandstrom G, Sjostedt A. Infrequent manifestations of tularaemia in Sweden. Scand J Infect Dis 1997; 29: 443446.
  • 125
    Evans ME, Gregory DW, Schaffner W et al. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 1985; 64: 251269.
  • 126
    Bachiller LP, Perez Castrillon JL, Martin LM et al. Preliminary report of an epidemic tularemia outbreak in Valladolid. Rev Clin Esp 1998; 198: 789793.
  • 127
    Montejo M, Perez-Irezabal J, Gonzalez DZ et al. Tularemia: report of 16 cases in the Castilla-Leon community. Rev Clin Esp 1998; 198: 794798.
  • 128
    Christenson B. An outbreak of tularemia in the northern part of central Sweden. Scand J Infect Dis 1984; 16: 285290.
  • 129
    Reintjes R, Dedushaj I, Gjini A et al. Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg Infect Dis 2002; 8: 6973.
  • 130
    Luotonen J, Syrjala H, Jokinen K et al. Tularemia in otolaryngologic practice. An analysis of 127 cases. Arch Otolaryngol Head Neck Surg 1986; 112: 7780.
  • 131
    Pettersson T, Nyberg P, Nordstrom D et al. Similar pleural fluid findings in pleuropulmonary tularemia and tuberculous pleurisy. Chest 1996; 109: 572575.
  • 132
    Penn RL, Kinasewitz GT. Factors associated with a poor outcome in tularemia. Arch Intern Med 1987; 147: 265268.
  • 133
    Roy TM, Fleming D, Anderson WH. Tularemic pneumonia mimicking Legionnaires' disease with false-positive direct fluorescent antibody stains for Legionella. South Med J 1989; 82: 14291431.
  • 134
    Syrjala H, Koskela P, Kujala P et al. Guillain–Barre syndrome and tularemia pleuritis with high adenosine deaminase activity in pleural fluid. Infection 1989; 17: 152153.
  • 135
    Blanco JR, Gutierrez C, Zabalza M et al. Clinical microbiological case: sore throat and painful bilateral cervical lymph nodes. Clin Microbiol Infect 2001; 7: 637636.
  • 136
    Sato T, Fujita H, Ohara Y et al. Microagglutination test for early and specific serodiagnosis of tularemia. J Clin Microbiol 1990; 28: 23722374.
  • 137
    Bevanger L, Maeland JA, Naess AI. Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia. J Clin Microbiol 1988; 26: 433437.
  • 138
    Viljanen MK, Nurmi T, Salminen A. Enzyme-linked immunosorbent assay (ELISA) with bacterial sonicate antigen for IgM, IgA, and IgG antibodies to Francisella tularensis: comparison with bacterial agglutination test and ELISA with lipopolysaccharide antigen. J Infect Dis 1983; 148: 715720.
  • 139
    Zeman P, Pazdiora P, Rebl K et al. Antibodies to granulocytic Ehrlichiae in the population of the western and central part of the Czech Republic. Epidemiol Mikrobiol Imunol 2002; 51: 1318.
  • 140
    Koskela P, Salminen A. Humoral immunity against Francisella tularensis after natural infection. J Clin Microbiol 1985; 22: 973979.
  • 141
    Bevanger L, Maeland JA, Kvan AI. Comparative analysis of antibodies to Francisella tularensis antigens during the acute phase of tularemia and eight years later. Clin Diagn Lab Immunol 1994; 1: 238240.
  • 142
    Hollis DG, Weaver RE, Steigerwalt AG et al. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J Clin Microbiol 1989; 27: 16011608.
  • 143
    Taylor JP, Istre GR, McChesney TC et al. Epidemiologic characteristics of human tularemia in the southwest–central states, 1981–1987. Am J Epidemiol 1991; 133: 10321038.
  • 144
    Limaye AP, Hooper CJ. Treatment of tularemia with fluoroquinolones: two cases and review. Clin Infect Dis 1999; 29: 922924.
  • 145
    Scofield RH, Lopez EJ, McNabb SJ. Tularemia pneumonia in Oklahoma, 1982–1987. J Okla State Med Assoc 1992; 85: 165170.
  • 146
    Sewell DL. Laboratory-associated infections and biosafety. Clin Microbiol Rev 1995; 8: 389405.
  • 147
    Burke DS. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis 1977; 135: 5560.
  • 148
    Provenza JM, Klotz SA, Penn RL. Isolation of Francisella tularensis from blood. J Clin Microbiol 1986; 24: 453455.
  • 149
    Brion JP, Recule C, Croize J et al. Isolation of Francisella tularensis from lymph node aspirate inoculated into a non-radiometric blood culture system. Eur J Clin Microbiol Infect Dis 1996; 15: 180181.
  • 150
    Reary BW, Klotz SA. Enhancing recovery of Francisella tularensis from blood. Diagn Microbiol Infect Dis 1988; 11: 117119.
  • 151
    Fournier PE, Bernabeu L, Schubert B et al. Isolation of Francisella tularensis by centrifugation of shell vial cell culture from an inoculation eschar. J Clin Microbiol 1998; 36: 27822783.
  • 152
    Dolan SA, Dommaraju CB, DeGuzman GB. Detection of Francisella tularensis in clinical specimens by use of polymerase chain reaction. Clin Infect Dis 1998; 26: 764765.
  • 153
    Sjostedt A, Eriksson U, Berglund L et al. Detection of Francisella tularensis in ulcers of patients with tularemia by PCR. J Clin Microbiol 1997; 35: 10451048.
  • 154
    Johansson A, Berglund L, Eriksson U et al. Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol 2000; 38: 2226.
  • 155
    Nutter JE. Antigens of Pasteurella tularensis: preparative procedures. Appl Microbiol 1971; 22: 4448.
  • 156
    Forsman M, Sandstrom G, Jaurin B. Identification of Francisella species and discrimination of type A and type B strains of F. tularensis by 16S rRNA analysis. Appl Environ Microbiol 1990; 56: 949955.
  • 157
    Forsman M, Sandstrom G, Sjostedt A. Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. Int J Syst Bacteriol 1994; 44: 3846.
  • 158
    Sandstrom G, Sjostedt A, Forsman M et al. Characterization and classification of strains of Francisella tularensis isolated in the central Asian focus of the Soviet Union and in Japan. J Clin Microbiol 1992; 30: 172175.
  • 159
    De La Puente-Redondo VA, Del Blanco NG, Gutierrez-Martin CB et al. Comparison of different PCR approaches for typing of Francisella tularensis strains. J Clin Microbiol 2000; 38: 10161022.
  • 160
    Johansson A, Ibrahim A, Goransson I et al. Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of Francisella tularensis. J Clin Microbiol 2000; 38: 41804185.
  • 161
    Karlsson J, Prior RG, Williams K et al. Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine. Microb Comp Genomics 2000; 5: 2539.
  • 162
    Anonymous. Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997; 46: 155.
  • 163
    Aznar P. Algunas investigationes clinicas y experimentales sobre la fiebre recurrente espanola. Arch Inst Nac Hig Alfonso XIII 1926; 4: 121127.
  • 164
    De Buen E, De La Camora P. Notas sobre 59 casos de fiebre recurrente espanola. Bol Tecn Dir San 1931; 6: 193207.
  • 165
    Anda P, Sanchez-Yebra W, Del Mar V et al. A new Borrelia species isolated from patients with relapsing fever in Spain. Lancet 1996; 348: 162165.
  • 166
    Fraenkel CJ, Garpmo U, Berglund J. Determination of novel Borrelia genospecies in Swedish Ixodes ricinus ticks. J Clin Microbiol 2002; 40: 33083312.
  • 167
    Van Dam AP, Van Gool T, Wetsteyn JC et al. Tick-borne relapsing fever imported from West Africa: diagnosis by quantitative buffy coat analysis and in vitro culture of Borrelia crocidurae. J Clin Microbiol 1999; 37: 20272030.
  • 168
    Cutler SJ, Akintunde CO, Moss J et al. Successful in vitro cultivation of Borrelia duttonii and its comparison with Borrelia recurrentis. Int J Syst Bacteriol 1999; 49: 17931799.
  • 169
    Poucher KL, Hutcheson HJ, Keirans JE et al. Molecular genetic key for the identification of 17 Ixodes species of the United States (Acari: Ixodidae): a methods model. J Parasitol 1999; 85: 623629.
  • 170
    Parola P, Inokuma H, Camicas JL et al. Detection and identification of spotted fever group Rickettsiae and Ehrlichiae in African ticks. Emerg Infect Dis 2001; 7: 10141017.
  • 171
    Sparagano O, Loria GR, Gubbels MJ et al. Integrated molecular diagnosis of Theileria and Babesia species of cattle in Italy. Ann NY Acad Sci 2000; 916: 533539.
  • 172
    Kleeman KT, Hicks JL, Anacker RL et al. Early detection of antibody to Rickettsia rickettsii: a comparison of four serological methods: indirect hemagglutination, indirect fluorescent antibody, latex agglutination, and complement fixation. In: KazarJ, ed. Rickettsiae and rickettsial diseases. Bratislava: Slovak Academy of Science, 1996; 171178.
  • 173
    Newhouse VF, Shepard CC, Redus MD et al. A comparison of the complement fixation, indirect fluorescent antibody, and microagglutination tests for the serological diagnosis of rickettsial diseases. Am J Trop Med Hyg 1979; 28: 387395.
  • 174
    Raoult D, De Micco C, Gallais H et al. Laboratory diagnosis of Mediterranean spotted fever by immunofluorescent demonstration of Rickettsia conorii in cutaneous lesions. J Infect Dis 1984; 150: 145148.
  • 175
    Roux V, Rydkina E, Eremeeva M et al. Citrate synthase gene comparison, a new tool for phylogenetic analysis, and its application for the rickettsiae. Int J Syst Bacteriol 1997; 47: 252261.
  • 176
    Bjoersdorff A, Brouqui P, Eliasson I et al. Serological evidence of Ehrlichia infection in Swedish Lyme borreliosis patients. Scand J Infect Dis 1999; 31: 5155.
  • 177
    Bakken JS, Dumler JS, Chen SM et al. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA 1994; 272: 212218.
  • 178
    Anderson BE, Dawson JE, Jones DC et al. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol 1991; 29: 28382842.
  • 179
    Comer JA, Nicholson WL, Sumner JW et al. Diagnosis of human ehrlichiosis by PCR assay of acute-phase serum. J Clin Microbiol 1999; 37: 3134.
  • 180
    Raoult D, Aboudharam G, Crubezy E et al. Molecular identification by ‘suicide PCR’ of Yersinia pestis as the agent of Medieval Black Death. Proc Natl Acad Sci USA 2000; 97: 1280012803.
  • 181
    Sumner JW, Nicholson WL, Massung RF. PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol 1997; 35: 20872092.
  • 182
    Wilske B, Zöller L, Brade V et al. MIQ 12 Lyme-Borreliose. In: MauchH, LüttickenR, eds. Qualitätsstandards in der mikrobiologisch infektiologischen diagnostik. München: Urban and Fischer, 2000.